In July 2015, The Ophthalmologist partnered with Market Scope to provide ophthalmologists in Europe with an opportunity to benchmark their practices against their peers, asking questions like: Which drugs do you prefer to use, how do you run your practice, what techniques do you plan to adopt, and what IOLs do you offer? The first quarterly European Ophthalmologist Survey went live on September 1, 2015, and ran to December 31, 2015. Invitations were extended to all subscribers to The Ophthalmologist, and European members of Practice-Scope, Market Scope’s online data portal. The survey questions focused on surgical volumes, techniques, new technology adoption and the latest trends with drug therapies.
Ophthalmologists from over 20 countries got involved, and their practices are represented in this analysis. All participants are from confirmed ophthalmic practices, and all individuals’ responses were de-identified. The data below provides some interesting insight into the variation in ophthalmic practices across the EU, and the full report is available free to subscribers to The Ophthalmologist, and ophthalmologists who take part in the survey. The full analysis is available online at: top.txp.to/0416/benchmark-practice, where you are also able to participate in the next survey. David Harmon is the Principal of Market Scope. He has more than 25 years of experience in the ophthalmic industry, and has written and published newsletters and market insight reports on the refractive surgery industry since 1996. Tony Ingenito is the Manager of Professional Services at Market Scope, and has worked in the field of eye heath since 2002.
